NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology-Reference-Cited by-同舟云学术

NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology

Published:2019-01 Issue: Volume:121 Page:338-349
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Mellone Manuela,Zianni Elisa,Stanic Jennifer^ORCID,Campanelli Federica,Marino Gioia,Ghiglieri Veronica,Longhi Annalisa,Thiolat Marie-Laure,Li Qin,Calabresi Paolo,Bezard Erwan,Picconi Barbara,Di Luca Monica,Gardoni Fabrizio^ORCID

Funder

Cariplo Foundation

Fondazione Umberto Veronesi

Agence Nationale de la Recherche

France Parkinson

Fondation de France

Medical Research Council

Innovative Medicines Initiative

Rotary Foundation

Aquitaine Regional Council

Publisher

Elsevier BV

Subject

Neurology

Reference76 articles.

1. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease;Ahmed;Sci. Transl. Med.,2010

2. Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity;Bai;Mol. Brain,2013

3. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease;Bastide;Prog. Neurobiol.,2015

4. Cholinergic neurons of the adult rat striatum are immunoreactive for glutamatergic N-methyl-d-aspartate 2D but not N-methyl-d-aspartate 2C receptor subunits;Bloomfield;Neuroscience,2007

5. Centrality of striatal cholinergic transmission in Basal Ganglia function;Bonsi;Front. Neuroanat.,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Aggregation of α-Synuclein in the Dorsomedial Striatum Significantly Impairs Cognitive Flexibility in Parkinson’s Disease Mice;Biomedicines;2024-07-23

2. NMDA receptor remodeling and nNOS activation in mice after unilateral striatal injury with 6-OHDA;Heliyon;2024-07

3. Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features;Brain, Behavior, and Immunity;2024-05

4. Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets;Progress in Neurobiology;2024-01

5. Neuroactive steroids and Parkinson’s disease: Review of human and animal studies;Neuroscience & Biobehavioral Reviews;2024-01